These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18841009)

  • 1. C-reactive protein: vascular risk marker in elderly patients with mental illness.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2008; 26(3):251-6. PubMed ID: 18841009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homocysteine and C-reactive protein are not markers of cognitive impairment in patients with major cardiovascular disease.
    Silbert B; Evered L; Scott DA; McCutcheon C; Jamrozik K
    Dement Geriatr Cogn Disord; 2008; 25(4):309-16. PubMed ID: 18311078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment.
    Xu G; Zhou Z; Zhu W; Fan X; Liu X
    J Neurol Sci; 2009 Sep; 284(1-2):77-80. PubMed ID: 19419739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2007; 24(3):162-8. PubMed ID: 17641526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time.
    Nilsson K; Gustafson L; Hultberg B
    Clin Biochem; 2011 Oct; 44(14-15):1205-8. PubMed ID: 21819975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of smoking on plasma folate and lipoproteins in Alzheimer disease, mild cognitive impairment and depression.
    Stuerenburg HJ; Ganzer S; Arlt S; Müller-Thomsen T
    Neuro Endocrinol Lett; 2005 Jun; 26(3):261-3. PubMed ID: 15990733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine and cognition in elderly patients with dementia or other psychogeriatric diseases.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2010; 30(3):198-204. PubMed ID: 20798540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Homocysteine--marker of vascular disease in elderly with mental illness].
    Hultberg B; Nilsson K; Gustafson L
    Lakartidningen; 2008 Sep 17-23; 105(38):2576-8. PubMed ID: 18846861
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risk factors for cognitive impairment].
    Cicconetti P; Riolo N; Priami C; Tafaro L; Ettore E
    Recenti Prog Med; 2004 Nov; 95(11):535-45. PubMed ID: 15598092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine and vascular disease in elderly patients with mental illness.
    Nilsson K; Gustafson L; Hultberg B
    Clin Chem Lab Med; 2008; 46(11):1556-61. PubMed ID: 18842107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular risk factors and Alzheimer's disease.
    Cechetto DF; Hachinski V; Whitehead SN
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of the dementias: an update.
    Qiu C; De Ronchi D; Fratiglioni L
    Curr Opin Psychiatry; 2007 Jul; 20(4):380-5. PubMed ID: 17551353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitivity C-reactive protein and cognitive function in older women.
    Weuve J; Ridker PM; Cook NR; Buring JE; Grodstein F
    Epidemiology; 2006 Mar; 17(2):183-9. PubMed ID: 16477259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialic acid, homocysteine and CRP: potential markers for dementia.
    Davis G; Baboolal N; Nayak S; McRae A
    Neurosci Lett; 2009 Nov; 465(3):282-4. PubMed ID: 19766699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine is elevated in elderly patients with memory complaints and vascular disease.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2007; 23(5):321-6. PubMed ID: 17374950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein and cognitive deficits in systemic lupus erythematosus.
    Shucard JL; Gaines JJ; Ambrus J; Shucard DW
    Cogn Behav Neurol; 2007 Mar; 20(1):31-7. PubMed ID: 17356342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain).
    Fernández Martínez M; Castro Flores J; Pérez de Las Heras S; Mandaluniz Lekumberri A; Gordejuela Menocal M; Zarranz Imirizaldu JJ
    BMC Neurol; 2008 Oct; 8():39. PubMed ID: 18922150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.
    Rodriguez-Oroz MC; Lage PM; Sanchez-Mut J; Lamet I; Pagonabarraga J; Toledo JB; García-Garcia D; Clavero P; Samaranch L; Irurzun C; Matsubara JM; Irigoien J; Bescos E; Kulisevsky J; Pérez-Tur J; Obeso JA
    Mov Disord; 2009 Jul; 24(10):1437-44. PubMed ID: 19452554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance.
    Sala I; Belén Sánchez-Saudinós M; Molina-Porcel L; Lázaro E; Gich I; Clarimón J; Blanco-Vaca F; Blesa R; Gómez-Isla T; Lleó A
    Dement Geriatr Cogn Disord; 2008; 26(6):506-12. PubMed ID: 19023204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.